PRLX-93936
98%
- Product Code: 109382
CAS:
903499-49-0
| Molecular Weight: | 364.44102 g./mol | Molecular Formula: | C₂₁H₂₄N₄O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
PRLX-93936 is primarily utilized in the field of medical research, particularly in the study of neurological disorders. It has shown potential in modulating specific pathways that are implicated in neurodegenerative diseases, making it a candidate for therapeutic development. Researchers are exploring its efficacy in conditions such as Alzheimer's disease and Parkinson's disease, where it may help in reducing neuronal damage and improving cognitive functions. Additionally, PRLX-93936 is being investigated for its role in enhancing synaptic plasticity, which is crucial for memory and learning processes. Its application extends to preclinical trials, where it is being assessed for safety, pharmacokinetics, and overall effectiveness in animal models. The compound's ability to cross the blood-brain barrier further enhances its potential as a viable treatment option for brain-related ailments.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | Ft437,902.85 |
+
-
|
PRLX-93936
PRLX-93936 is primarily utilized in the field of medical research, particularly in the study of neurological disorders. It has shown potential in modulating specific pathways that are implicated in neurodegenerative diseases, making it a candidate for therapeutic development. Researchers are exploring its efficacy in conditions such as Alzheimer's disease and Parkinson's disease, where it may help in reducing neuronal damage and improving cognitive functions. Additionally, PRLX-93936 is being investigated for its role in enhancing synaptic plasticity, which is crucial for memory and learning processes. Its application extends to preclinical trials, where it is being assessed for safety, pharmacokinetics, and overall effectiveness in animal models. The compound's ability to cross the blood-brain barrier further enhances its potential as a viable treatment option for brain-related ailments.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :